Related by context. All words. (Click for frequent words.) 81 Multiple logistic regression 77 multivariate logistic regression 77 conditional logistic regression 76 multivariable logistic regression 75 multiple logistic regression 75 Logistic regression 74 Poisson regression 73 Multiple linear regression 73 meta regression 72 univariate 72 Univariate 71 Logistic regression analysis 71 logistic regression models 71 Multivariable logistic regression 71 logistic regression analyzes 71 multiple linear regression 71 logistic regression analysis 70 multivariate Cox 70 Multivariate analysis 69 retrospective cohort 69 multivariate analyzes 68 Subgroup analyzes 68 metaanalysis 68 univariate analyzes 68 logistic regression model 68 Mantel Haenszel 68 prospective observational studies 68 Meta analyzes 68 electrophysiologic 68 variance ANOVA 67 F FDG PET 67 perfusion MRI 67 semiquantitative 67 Kaplan Meier survival 67 ConclusionThis 67 HIV tropism 67 immunohistochemical 67 Subgroup analysis 67 urolithiasis 67 multivariate regression 67 transvaginal sonography 67 histopathologic 67 Multivariate analyzes 67 multivariable analysis 66 prostate cancer CaP 66 differential gene expression 66 intraobserver 66 histopathological 66 histologic findings 66 prospective multicenter study 66 stepwise logistic regression 66 Linear regression 66 logistic regression 66 multivariate regression analysis 66 Univariate analysis 66 acetabular fractures 66 Histologic 66 convergent validity 66 multivariable Cox 66 prognostic variables 66 tumor histology 66 Histopathologic 66 Observational studies 66 FDG PET imaging 66 explanatory variables 66 pharmacodynamic parameters 66 immunohistochemical analysis 66 NHAMCS 66 clinicopathologic 66 Computed tomography 66 bivariate 65 cytologic 65 spirometric 65 binary logistic regression 65 Descriptive statistics 65 dosimetric 65 FDG-PET/CT 65 color Doppler sonography 65 interobserver reliability 65 genotypic resistance 65 Cardiorespiratory fitness 65 generalized linear 65 covariate 65 bronchopulmonary dysplasia BPD 65 transcranial Doppler 65 transesophageal echocardiography 65 clinicopathological 65 colonoscopic 65 Sensitivity analyzes 65 clinico pathological 65 linear regression analyzes 65 nodal metastasis 64 renal biopsy 64 Kaplan Meier method 64 randomized controlled trials RCTs 64 transient elastography 64 Secondary efficacy endpoints 64 etiologic 64 sonographically guided 64 urodynamic 64 oncologic outcomes 64 HPA Consultants 64 symptomatic VTE 64 RE LY trial 64 Regression analyzes 64 Pharmacodynamic 64 histopathologic examination 64 MDRD 64 sonographic findings 64 HER2 overexpression 64 Plain radiographs 64 tumorigenicity 64 interobserver 64 histological subtype 64 ImmuKnow assay 64 transabdominal 64 stratifying patients 64 immunohistochemical staining 64 metabolite concentrations 64 venous thromboembolic disease 64 Flow cytometry 64 relapsed MM 64 multivariable adjusted 64 histopathologic diagnosis 64 proportional hazards 64 prostate cancer PCa 64 PIB PET 64 pulp metallic 64 Histopathological 64 dose proportionality 64 Lymph node 64 postoperative pulmonary 64 Randomized clinical trials 64 prospective multicentre 64 coronary stenosis 64 serum biomarkers 64 System IPSS 64 bivariate analysis 63 #F FDG PET 63 differentiate squamous 63 Tumor Response 63 miRNA expression 63 Doppler echocardiography 63 enzyme immunoassay EIA 63 intra abdominal abscess 63 logistic regressions 63 Western blotting 63 radiographic findings 63 transthoracic 63 hepatic arterial 63 FDG PET CT 63 Histological 63 QTc prolongation 63 radiographic outcomes 63 ultrasonographic 63 glomerular filtration 63 percutaneous biopsy 63 Abdominal ultrasound 63 microalbumin 63 anthropometric measurements 63 K ras mutations 63 angiographically 63 nonparametric 63 functional neuroimaging 63 computed tomographic 63 biopsied tissue 63 mammographic density 63 HER2 expression 63 induced sputum 63 cerebral microbleeds 63 genomewide 63 Microarray analysis 63 ANOVA 63 Genotypic 63 vascular endothelial dysfunction 63 Skin sterol 63 pathogenetic mechanisms 63 histopathological examination 63 haematologic 62 transcranial Doppler ultrasound 62 thoracoscopic lobectomy 62 HRCT 62 neuropsychological assessment 62 Symptom severity 62 meta analytic 62 transrectal ultrasound 62 chi squared 62 ANCOVA 62 genetic polymorphisms 62 Non inferiority 62 ductal carcinomas 62 generalized estimating 62 confidence intervals CIs 62 intact parathyroid hormone 62 pathologic examination 62 chest radiographs 62 esophageal carcinoma 62 Zevalin consolidation 62 prostate carcinoma 62 Carotid Revascularization Endarterectomy vs. 62 microarray gene expression 62 neurosensory 62 hemodynamic measurements 62 pathologic fractures 62 histopathologic findings 62 Liver biopsy 62 echocardiographic 62 radiation dosimetry 62 cardiac perfusion 62 AST ALT 62 cerebral angiography 62 Immunohistochemical analysis 62 Kruskal Wallis test 62 Kaplan Meier analysis 62 Intermountain Risk Score 62 metastatic lymph nodes 62 Heavy menstrual bleeding 62 colorectal adenoma 62 preoperative MRI 62 EUS FNA 62 retrospective observational study 62 chromosomal mutations 62 prospective longitudinal 62 Microscopic examination 62 cardiac repolarization 62 plain radiographs 62 cardiac troponin T 62 Computed tomographic 62 preclinical efficacy 62 percutaneous vertebroplasty 62 Ultrasonographic 62 endometrial hyperplasia 62 pharmacodynamic markers 62 nonpharmacologic 62 tissue microarrays 62 bone scintigraphy 62 haemodynamic 62 NATRECOR ® 62 Finite element 62 neurocognitive function 62 contrast echocardiography 62 LVNC 62 esophageal reflux 62 serum GGT 62 retrospective cohort study 62 BEXXAR Therapeutic Regimen 62 prostate carcinogenesis 62 premorbid 62 prognostic indicators 62 Randomised controlled trials 62 HIV HCV coinfected 62 metabolomic profiling 62 transthoracic echocardiography 62 NSCLC tumors 62 Immunohistochemical staining 62 scintigraphic 61 HBV infections 61 Randomized trials 61 multivariable regression 61 Cardiotoxicity 61 Coronary angiography 61 postoperative complication 61 perioperative morbidity 61 physiologic parameters 61 intraoperative complications 61 prespecified secondary 61 FDG PET 61 gauge vitrectomy 61 NHANES III 61 Echocardiographic 61 ECLS 61 immunostaining 61 bioprosthetic valve 61 Radical prostatectomy 61 Bonferroni correction 61 APOE genotype 61 fetal chromosomal 61 Coronary CTA 61 multivariable analyzes 61 vivo assays 61 differentially expressed genes 61 Prognostic factors 61 histologic examination 61 inferential statistics 61 CP CPPS 61 duplex ultrasonography 61 Rigorous scientific 61 psychiatric comorbidities 61 Multivariable 61 ADVEXIN therapy 61 virologic responses 61 EQ 5D 61 genomic alterations 61 Ebstein anomaly 61 covariance ANCOVA 61 hepatic lesions 61 fetal echocardiography 61 basal bolus regimen 61 RRM1 61 Bonferroni 61 left ventricular diastolic 61 methodologic 61 CYP#D# genotype 61 adnexal masses 61 hematopoietic cancers 61 fluorodeoxyglucose positron emission tomography 61 transrectal ultrasound guided 61 coagulation parameters 61 myocardial viability 61 VerifyNow P#Y# 61 Cytogenetic 61 hemostatic efficacy 61 Serological 61 mucinous 61 riociguat 61 sociodemographic factors 61 NAMCS 61 osteoid 61 developmental neurotoxicity 61 urothelial carcinoma 61 Pharmacokinetic parameters 61 SpCO 61 cytological 61 mean ± SEM 61 transcriptomic 61 genotypic 61 Pearson correlation coefficients 61 eTag assays 61 RECIST Response Evaluation Criteria 61 atherothrombotic disease 61 nonrandomized 61 Radiographs 61 CT perfusion 61 adjuvant systemic 61 exploratory endpoints 61 parasitological 61 atherothrombotic 61 metaplasia 61 chest radiograph 61 CT urography 61 hip resurfacing arthroplasty 61 odds ratios ORs 61 subgroup analyzes 61 STEP BD 61 aminotransferases 61 adnexal mass 61 sputum induction 61 morphometric vertebral fractures 61 Tasigna prolongs 61 familial clustering 61 hyperinsulinemic euglycemic clamp 61 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 61 node metastases 61 immunoblotting 61 quasispecies 61 Coronary artery bypass grafting 61 observational cohort study 61 morphometrics 61 prognostic significance 61 Postoperative complications 61 histologic subtype 61 susceptibility loci 61 thorough QT 61 anti JCV antibodies 61 troponins 61 arteriography 61 molecular determinants 61 viral kinetics 61 CHAMPION PCI 61 CSF biomarkers 61 urothelial cancer 61 predictive validity 61 allele frequencies 60 hematologic parameters 60 florbetaben 60 antiepileptics 60 ASCUS 60 carotid plaques 60 NMIBC 60 endometrial carcinoma 60 prospective observational cohort 60 EGFR mutation status 60 SYNTAX trial 60 Kaplan Meier curves 60 tumor subtype 60 myocardial ischaemia 60 SEER registry 60 BPS IC 60 residual confounding 60 Logistic regression analyzes 60 gadolinium enhanced 60 LV dysfunction 60 Electrophysiological 60 endoscopic retrograde 60 orofacial clefts 60 DNA methylation patterns 60 neurologic complications 60 proton MR spectroscopy 60 postoperative AF 60 HOMA IR 60 MTT assay 60 Efficacy endpoints 60 coronary CTA 60 Preoperative 60 clinicopathological features 60 postmarketing adverse 60 multicenter trials 60 transesophageal 60 spontaneous regression 60 Aspergillus nidulans 60 symptomatic pulmonary embolism 60 hematological parameters 60 IntroductionThe 60 hepatorenal syndrome 60 Immunohistochemical 60 sonographic diagnosis 60 KRAS mutation 60 RT qPCR 60 galiximab 60 transcriptional profiling 60 biochemical recurrence 60 Kaplan Meier curve 60 genomewide association study 60 breast carcinoma 60 postoperative atrial fibrillation 60 renal cysts 60 pelvic lymphadenectomy 60 colorectal neoplasia 60 computerized tomography scan 60 pulmonary artery banding 60 Post hoc 60 covariates 60 chlamydial infection 60 SLNB 60 hsCRP levels 60 sociodemographic characteristics 60 GRNCM1 60 hamartoma 60 BUSM researchers 60 CTEPH 60 flurpiridaz F 60 liver biopsies 60 toxicologic 60 DSM IV diagnoses 60 transfusion syndrome 60 pharmacodynamic effects 60 papillary renal cell carcinoma 60 longitudinal cohort study 60 inflammatory biomarkers 60 thoracolumbar spine 60 p# biomarker 60 Phylogenetic analyzes 60 precaution Wiehle 60 plasma pharmacokinetics 60 autonomic dysfunction 60 chest radiography 60 Lp PLA 2 60 metastatic neuroendocrine tumors 60 Solid Tumours 60 sensitivity specificity 60 histologic 60 follicular adenoma 60 postintervention 60 IMPACT DCM 60 bronchoalveolar 60 Epidemiologic studies 60 ExTRACT TIMI 60 ROC curves 60 preimplantation 60 FGFR2 gene 60 pleural fluid 60 eculizumab therapy 60 hepatic liver 60 neurocognitive impairment 60 clinically localized prostate 60 β blockers 60 Vizilite 60 RQ PCR 60 rs# [004] 60 ultrastructural 60 splenic 60 variant rs# 60 syndromic 60 arthrography 60 deCODE BreastCancer TM 60 CaPSURE 60 morphologic 60 MR spectroscopy 60 STRIDE PD 60 Multivariate 60 Primary endpoints 60 antitumour activity 60 recurrent glioblastoma multiforme 60 regression analyzes 60 Kaplan Meier 60 serum leptin 60 postoperative infections 60 neuropathological 60 Longitudinal studies 60 postoperative hemorrhage 60 oncological outcomes 60 KRAS status 60 SUVmax 60 amphetamine methamphetamine 60 INTERHEART study 60 neurophysiologic 60 coagulation abnormalities 60 mediastinal lymph nodes 60 spiral computed tomography 60 ADAGIO study 60 microsatellite instability 60 Venous thromboembolism 60 Surgical excision 60 estimated glomerular filtration 60 neuropathologic 60 diagnostic prognostic 60 univariate analysis 60 HRQL 60 glycosylated hemoglobin HbA1c 60 probabilistic modeling 60 FDG uptake 60 karyotypes 60 SNP rs# [002] 60 schizophreniform disorder 60 Febrile neutropenia 60 psychopathological symptoms 60 prospectively stratified 60 vascular dysfunction 60 obstetric ultrasound 60 transgene expression 60 Estrogen Receptor 60 genomic biomarker 60 liposomal amphotericin B 60 Reynolds Risk Score 60 MDCT angiography 60 enteroviral infection 60 Pharmacokinetic PK 60 fetal malformations 60 QTcF 60 Corus CAD 60 recurrent venous thromboembolism 60 pathologic diagnosis 60 sputum specimens 60 semistructured interviews 60 endocrinologic 60 Cardiopulmonary bypass 60 stent graft placement 60 adenotonsillectomy 60 nodal metastases 60 depressive symptomatology 60 core needle biopsies 60 MGUS 59 subclinical disease 59 sonographic evaluation 59 antiangiogenic agents 59 EuroSCORE 59 CARE HF 59 Sonographic 59 tolerability pharmacokinetics 59 singleton pregnancies 59 perioperative mortality 59 ER CHOP 59 VP# [004] 59 pharmacokinetic interactions 59 intravascular hemolysis 59 polysomnogram 59 Interrater reliability 59 bazedoxifene conjugated estrogens 59 Pharmacokinetic 59 AtherOx 59 psychiatric comorbidity 59 noncardiac 59 preoperative evaluation 59 IPAH 59 morphometry 59 esophagogastric 59 somatoform disorders 59 NPM1 mutation 59 Liver biopsies 59 lesional 59 cerebral oxygenation 59 MiCK assay 59 CIN2 + 59 Phenotypic 59 pharmacodynamic profiles 59 cisplatin resistant 59 posterior cervical 59 excisional biopsy 59 T1 weighted images 59 preoperative PSA 59 lung nodule 59 gastric carcinoma 59 eNO 59 prospective nonrandomized 59 echocardiographic parameters 59 nomograms 59 CD# expression [001] 59 vitro experiments 59 transrectal ultrasonography 59 antiplatelet therapies 59 postoperative mortality 59 urethral stricture 59 Electroencephalography 59 abnormal cytology 59 pulmonary toxicity 59 hemodynamic variables 59 pharmacokinetics PK 59 stone formers 59 correlational 59 pharmacokinetic parameters 59 Cardiac catheterization 59 sporadic Creutzfeldt Jakob 59 esophageal manometry 59 GH deficiency 59 sociodemographic 59 chlamydial 59 fluorescein angiography 59 HNSCC 59 Logistic regression models 59 sonographic 59 incomplete revascularization 59 hamartomas 59 ovarian malignancy 59 DLQI 59 PSA kinetics 59 gastric cardia 59 kidney urologic 59 radiofrequency catheter ablation 59 bronchial lavage 59 tissue perfusion 59 carotid IMT 59 DEXA scan 59 postdischarge 59 emotional dysregulation 59 SLN biopsy 59 helical CT 59 pericardial effusion 59 PROactive study 59 bronchoalveolar lavage BAL 59 socioeconomic variables 59 nested PCR 59 conventional angiography 59 NIHSS score 59 intrapartum 59 atypical hyperplasia 59 Sentinel Lymph Node Biopsy 59 microvessel density 59 SELDI TOF MS 59 aldosterone antagonist 59 extracolonic findings 59 myocardial revascularization 59 calcaneal fractures 59 trastuzumab Herceptin ® 59 antiangiogenic therapy 59 genotype phenotype 59 neurodevelopmental outcome 59 ultrasonographic examination 59 covariance 59 Depressive symptoms 59 leiomyoma 59 preoperative staging 59 Postoperative 59 empirically validated 59 histological subtypes 59 airway hyperresponsiveness 59 serum phosphorous 59 cardioembolic stroke 59 electrocardiography ECG 59 viral tropism 59 dimensional sonography 59 RVOT 59 angiographic outcomes 59 VKORC1 59 hepatic cirrhosis 59 TURBT 59 thyrotropin 59 upper endoscopies 59 FDG PET scans 59 idiopathic pulmonary 59 biostatistical analysis 59 posttreatment 59 lymphadenectomy 59 DAS# CRP 59 N glycan 59 urodynamic studies 59 bivariate analyzes 59 underwent coronary angiography 59 #S rRNA gene 59 hypercalciuria 59 aneuploidy screening 59 thromboembolic disease 59 actigraphy 59 CYT# potent vascular disrupting 59 perinatal outcomes 59 pelvic ultrasound 59 bronchial hyperresponsiveness 59 EBUS FNA 59 Intussusception 59 Fetal Fibronectin Test 59 hepatic fibrosis 59 poststroke 59 sonographic examination 59 WOMAC pain 59 hepatocellular carcinomas 59 femoral neck fracture 59 sleeve lobectomy 59 nucleotide substitutions 59 metabolomic profiles 59 quantitative RT PCR 59 Virological 59 NSABP B 59 chromosomal aberrations 59 neoadjuvant therapy 59 mitral annular 59 endoscopic ultrasonography 59 hydroxy vitamin D 59 generalisability 59 serum markers 59 Wilcoxon rank sum 59 TRUS 59 AGHD 59 fundus photography 59 pharmacokinetic PK 59 nutrient supplementation 59 VCUG 59 extrapulmonary disease 59 nonvertebral fracture 59 overnight polysomnography 59 d dimer 59 cytoreductive nephrectomy 59 pharmacokinetic pharmacodynamic 59 Doppler ultrasonography 59 microRNA expression 59 selenium supplementation 59 psychometric properties 59 postprocedure 59 serum clusterin levels 59 pathologic fracture 59 mammographically 59 Response Evaluation Criteria 59 miRview ™ squamous 59 analgesic medications 59 rFVIIa 59 unmeasured confounders 59 serum cotinine 59 AVERROES 59 rebleeding 59 Child Behavior Checklist 59 Genetic variants 59 demonstrated clinically meaningful 59 DCE MRI 59 immunochemical 59 gene expression microarrays 59 NIH CPSI 59 Confocal microscopy 59 lymph node metastasis 59 proximal femur 59 renal cell carcinomas 59 Radiographic 59 renal tumors 59 cervical carcinoma 59 hemodilution 59 Immunohistochemistry 59 pharmacokinetic characteristics 59 genetic loci 59 KRAS mutation status 59 tumor subtypes 59 Uncontrolled hypertension 59 erythema nodosum 59 clefting 59 endocervical 59 Helicobacter infection 59 serum antibody 59 cystoscopic 59 chronicity 59 locoregional 59 Insulin sensitivity 59 thromboembolism 59 morphometric 59 perfusion abnormalities 59 RE LY ® 59 neurocognitive functioning 59 pulmonary angiography 59 EORTC QLQ C# 59 radical cystectomy 59 Cochrane reviewers 59 urine dipstick 59 preoperative diagnosis 59 sputum cytology 59 neuroanatomical 59 familial aggregation 59 ragweed allergic 59 Neuropsychiatric Inventory NPI 59 Mathematical modeling 59 MVA MUC1 IL2 59 postoperative radiographs 59 GYTS 58 morphometric analysis 58 erection hardness 58 KRAS gene mutations 58 extramedullary 58 dyssynchrony 58 BioMAP ® 58 computed tomographic scan 58 polysomnography PSG 58 quantitative trait loci 58 antidiabetic medication 58 needle aspiration 58 lymph node dissection 58 MAGE A3 ASCI 58 Negative Symptoms 58 diffusion tensor 58 sentinel lymph node biopsy 58 FUS protein 58 neurodevelopmental outcomes 58 metabolic parameters 58 prospectively defined 58 noncardiovascular 58 lactate dehydrogenase 58 Fine needle aspiration 58 electroencephalographic 58 EBMT criteria 58 liver metastasis 58 Sociodemographic 58 medically inoperable 58 COMT genotype 58 nonpsychiatric 58 aetiological 58 causative mutations 58 aminotransferase levels 58 chemosensitivity 58 serum cotinine levels 58 pancreatic adenocarcinoma 58 Histopathologic examination 58 Hepatotoxicity 58 somatic mutations 58 multivariate analysis 58 multivariable 58 intima media thickness 58 F FDG uptake 58 catheter ablations 58 HRQOL 58 Magnetic resonance 58 axillary lymph node 58 multicentric 58 Computed Tomography CT scans 58 microdose 58 monogenic 58 gross hematuria 58 semistructured interview 58 Hp2 2 58 intraventricular 58 biochemical abnormalities 58 pretest probability 58 waist circumference WC 58 cardiac magnetic resonance 58 confounder 58 liver transplant recipients 58 radioimmunoassay 58 PSA nadir 58 Adjuvant therapy 58 subclinical atherosclerosis 58 proteomic analysis 58 ELISpot 58 DNA methylation markers 58 hypogonadotropic hypogonadism 58 pharmacodynamic PD 58 biopsy specimens 58 histological examination 58 corneal topography 58 Brief Psychiatric 58 nucleosome positioning 58 Ultrasonography 58 delafloxacin 58 prehospital setting 58 prospectively randomized 58 bronchoalveolar lavage 58 endoscopic examinations 58 pre operatively 58 gastric adenocarcinoma 58 computed tomographic scans 58 sacral neuromodulation 58 cardiac troponin 58 Subarachnoid hemorrhage 58 PCWP 58 nomogram 58 busulfan 58 pulmonary metastasis 58 percutaneous drainage 58 Quantitative RT PCR 58 postoperative morbidity 58 microcirculatory 58 atherogenic dyslipidemia 58 interrater reliability 58 dimensional echocardiography 58 dobutamine stress 58 fibrotic disease 58 PSMA ADC 58 extrapyramidal symptoms 58 steroid dexamethasone 58 warfarin dosage 58 OBPM 58 vitro cytotoxicity 58 computed tomography CT scan 58 CORE OM 58 synovial tissue 58 thromboembolic complications 58 FluCAM arm 58 tumor regressions 58 monoclonal gammopathy 58 pharmacodynamic endpoints 58 functional MRI fMRI 58 distant metastasis 58 abdominal ultrasound 58 SSc 58 TNM staging 58 extracapsular extension 58 NLSY 58 sonographically 58 psychosocial variables 58 cervicitis 58 GnRH agonist 58 anti Mullerian hormone 58 serological 58 PSADT 58 S. maltophilia 58 beta carotene supplementation 58 carcinomatosis 58 STRATEGY FOR AN OPEN 58 miRview squamous 58 chromosomal anomalies 58 liver histology 58 paricalcitol 58 BSGI MBI 58 aneurysmal subarachnoid hemorrhage 58 antemortem 58 Index CDAI 58 PCI ExTRACT TIMI 58 osteocalcin protein 58 HIV seroconversion 58 preoperative intraoperative 58 pharmacokinetic equivalence 58 Oncotype 58 preintervention 58 serum lipid levels 58 TMPRSS2 ERG fusion 58 LRP5 58 pharmacogenetic tests 58 genes differentially expressed 58 subthreshold depression 58 magnetic resonance spectroscopy MRS 58 pretransplant 58 biodistribution studies 58 teriflunomide 58 invasive carcinoma 58 proteomic analyzes 58 trials RCTs 58 antiplatelet medications 58 Sjögren syndrome 58 ToGA 58 metabolic dysfunction 58 tigecycline 58 computerized tomography scans 58 pulmonary dysfunction 58 psychiatric morbidity 58 predictive biomarker 58 ventricular myocardium 58 differentially expressed proteins 58 urine cytology 58 APTIMA HPV 58 #beta estradiol 58 pharmacodynamic properties 58 Cystatin C 58 RT PCR assay 58 perioperative complications 58 electrocardiographic 58 IGRAs 58 PROCHYMAL 58 NNT = 58 specific antigen PSA 58 variography 58 recurrent miscarriage 58 DAVANAT R exhibits 58 multivariate adjustment 58 Heritability 58 TCF#L# gene 58 Coronary Artery Bypass Graft 58 IVIVC 58 elective PCI 58 estimated GFR 58 hyperplastic 58 lymphoma subtypes 58 multivariate statistical 58 Scintigraphy 58 hemodynamic parameters 58 tumor necrosis 58 radiolabeled TM# 58 carotid plaque 58 IMPROVE HF